Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/30363
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Data de embargo
2038-08-30
Coleções
- INI - Artigos de Periódicos [3397]
Metadata
Mostrar registro completo
HEPATOTOXICITY DURING ISONIAZID PREVENTIVE THERAPY AND ANTIRETROVIRAL THERAPY IN PEOPLE LIVING WITH HIV WITH SEVERE IMMUNOSUPPRESSION: A SECONDARY ANALYSIS OF A MULTI-COUNTRY OPEN-LABEL RANDOMIZED CONTROLLED CLINICAL TRIAL
Autor(es)
Afiliação
UNC-Project Malawi. Lilongwe, Malawi./ Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
University of Pennsylvania. Perelman School of Medicine. Philadelphia, PA, USA.
Johns Hopkins University. School of Medicine. Baltimore, MD, USA.
Johns Hopkins Project. Blantyre, Malawi.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil./ Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Johns Hopkins Project. Blantyre, Malawi.
Case Western Research Collaboration (JCRC). Kampala, Uganda.
UNC-Project Malawi. Lilongwe, Malawi./ North Carolina School of Medicine. Chapel Hill, NC, USA.
Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
University of Pennsylvania. Perelman School of Medicine. Philadelphia, PA, USA.
Johns Hopkins University. School of Medicine. Baltimore, MD, USA.
Johns Hopkins Project. Blantyre, Malawi.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil./ Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research. Boston, MA, USA.
Johns Hopkins Project. Blantyre, Malawi.
Case Western Research Collaboration (JCRC). Kampala, Uganda.
UNC-Project Malawi. Lilongwe, Malawi./ North Carolina School of Medicine. Chapel Hill, NC, USA.
Resumo em Inglês
Hepatotoxicity associated with isoniazid preventive therapy (IPT) and antiretroviral therapy (ART) has not been well studied in severely immunosuppressed people with HIV. Our objective was to determine risk factors for hepatotoxicity in severely immunosuppressed individuals taking IPT and ART.
Compartilhar